The Muddle of Models: What You Donʼt Know Can Hurt You

Prior to clinical trials, animal models remain the primary tools by which the pharmaceutical industry demonstrates the efficacy and safety of candidate therapeutic agents. Despite this reliance, much remains unknown about the models that we use and the factors that affect how they perform. This igno...

Full description

Saved in:

Bibliographic Details
Published in:	Chemical research in toxicology 2008-10, Vol.21 (10), p.1917-1922, Article 1917
Main Author:	Robertson, Donald G
Format:	Article
Language:	eng
Subjects:	Animals Biotechnology Creatine Kinase - metabolism Diet Drug Evaluation, Preclinical - methods Drug Evaluation, Preclinical - standards Humans Magnetic Resonance Spectroscopy Models, Animal Models, Biological
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Prior to clinical trials, animal models remain the primary tools by which the pharmaceutical industry demonstrates the efficacy and safety of candidate therapeutic agents. Despite this reliance, much remains unknown about the models that we use and the factors that affect how they perform. This ignorance can lead to inappropriate assumptions, questionable procedures, and incorrect conclusions from data generated in these models. This perspective provides a narrative of several such instances and provides recommendations as to how we might address our knowledge gap by better characterization of our models, better understanding of our practices, and better control of our studies.
ISSN:	0893-228X 1520-5010